<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Curr Glaucoma Pract</journal-id><journal-id journal-id-type="iso-abbrev">J Curr Glaucoma Pract</journal-id><journal-id journal-id-type="publisher-id">JOCGP</journal-id><journal-title-group><journal-title>Journal of Current Glaucoma Practice</journal-title></journal-title-group><issn pub-type="ppub">0974-0333</issn><issn pub-type="epub">0975-1947</issn><publisher><publisher-name>Jaypee Brothers Medical Publishers</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">PMC9385389</article-id><article-id pub-id-type="doi">10.5005/jp-journals-10078-1352</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>A Review of Excisional Goniotomy Performed with the Kahook Dual Blade for Glaucoma Management</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Dorairaj</surname><given-names>Syril</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="cor1" ref-type="corresp"/></contrib><contrib contrib-type="author"><name><surname>Radcliffe</surname><given-names>Nathan M</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Grover</surname><given-names>Davinder S</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Brubaker</surname><given-names>Jacob W</given-names></name><xref rid="aff4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>Williamson</surname><given-names>Blake K</given-names></name><xref rid="aff5" ref-type="aff">5</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Department of Ophthalmology, Mayo Clinic College of Medicine, Jacksonville, Florida, United States</aff><aff id="aff2"><label>2</label>Department of Ophthalmology, Mount Sinai School of Medicine, New York, United States</aff><aff id="aff3"><label>3</label>Glaucoma Associates of Texas, Dallas, Texas, United States</aff><aff id="aff4"><label>4</label>Sacramento Eye Consultants, Sacramento, California, United States</aff><aff id="aff5"><label>5</label>Williamson Eye Center, Baton Rouge, Louisiana, United States</aff><author-notes><corresp id="cor1">Syril Dorairaj, Department of Ophthalmology, Mayo Clinic College of Medicine, Jacksonville, Florida, United States, Phone: +<bold>1</bold> 904-953-2377, e-mail: <email>syrildorairajmd@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jan-Apr</season><year>2022</year></pub-date><volume>16</volume><issue>1</issue><fpage>59</fpage><lpage>64</lpage><permissions><copyright-statement>Copyright &#x000a9; 2022; The Author(s).</copyright-statement><copyright-year>2022</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>&#x000a9; The Author(s). 2022 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract><title>A<sc>bstract</sc></title><sec><title>Aim</title><p>To review the published literature describing clinical outcomes of excisional goniotomy using the Kahook Dual Blade (KDB) for the management of glaucoma.</p></sec><sec><title>Background</title><p>A family of less invasive glaucoma procedures&#x02014;including excisional goniotomy with the KDB&#x02014;has been developed to provide moderate reductions in intraocular pressure and/or medication burden in eyes with therapeutic needs that may not warrant the risks associated with more traditional procedures such as trabeculectomy and tube-shunt implantation. This review's goal is to synthesize the existing literature into a compendium of excisional goniotomy's indications, technique, efficacy and safety outcomes, and optimal place in glaucoma management.</p></sec><sec><title>Review results</title><p>Excisional goniotomy with the KDB effectively lowers IOP and reduces the medication burden in eyes with POAG and other forms of glaucoma across the spectrum of both baseline IOP and disease severity. The procedure exhibits a safety profile that is on par with other angle-based surgical interventions and enhanced safety compared to filtration procedures. It can be performed by comprehensive ophthalmologists as well as glaucoma specialists. This procedure as a standalone operation delivers IOP reductions consistent with filtration surgery, and in combination with cataract surgery delivers both IOP and medication reductions at least as great as other minimally invasive procedures.</p></sec><sec><title>Conclusion</title><p>Given the broad base of evidence supporting its use in a wide variety of clinical scenarios, excisional goniotomy with the KDB can play a meaningful role in the achievement of patient-specific glaucoma therapy goals.</p></sec><sec><title>Clinical significance</title><p>These aggregate findings support the efficacy and safety of excisional goniotomy with the KDB and clarify the patient profiles best suited for this procedure.</p></sec><sec><title>How to cite this article</title><p>Dorairaj S, Radcliffe NM, Grover DS, <italic>et al.</italic> A Review of Excisional Goniotomy Performed with the Kahook Dual Blade for Glaucoma Management. J Curr Glaucoma Pract 2022;16(1):59&#x02013;64.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>Glaucoma</kwd><kwd>Glaucoma surgery</kwd><kwd>Goniotomy</kwd><kwd>Kahook Dual Blake</kwd><kwd>Systematic review</kwd></kwd-group></article-meta></front><body><sec sec-type="background"><title>B<sc>ackground</sc></title><sec><title>Goniotomy Then and Now</title><p>Goniotomy was first described by Barkan as the incision of one quarter to one-third of the nasal trabecular meshwork (TM) <italic>via</italic> a temporal peripheral corneal incision under intraoperative gonioscopy in a series of 11 adult eyes in 1936.<sup><xref rid="B1" ref-type="bibr">1</xref></sup> The first PubMed-indexed case of goniotomy in a child came in 1944.<sup><xref rid="B2" ref-type="bibr">2</xref></sup> Scheie subsequently more fully characterized goniotomy in congenital glaucoma,<sup><xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B4" ref-type="bibr">4</xref></sup> and by 1953 in the Jackson Memorial Lecture, Barkan conceded that this procedure's indication was limited to congenital glaucoma.<sup><xref rid="B5" ref-type="bibr">5</xref></sup> In the late 20th century, several variations of goniotomy for adult glaucoma (both laser<sup><xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B7" ref-type="bibr">7</xref></sup> and incisional<sup><xref rid="B8" ref-type="bibr">8</xref></sup>) were described but did not gain traction clinically. Amidst recent rapid expansion of glaucoma surgical options, and with a focus on minimally invasive approaches, goniotomy for adult eyes with glaucoma has reemerged as a viable option.</p><p>Excisional goniotomy using the Kahook Dual Blade (KDB, New World Medical, Rancho Cucamonga, CA) is one of several innovative glaucoma procedures developed in recent years to satisfy unmet needs in the surgical glaucoma arena for a safer surgical option. Traditional procedures such as trabeculectomy and tube-shunt implantation are highly effective in both lowering intraocular pressure (IOP) and achieving low target IOPs, but these procedures are associated with well-described safety issues<sup><xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B10" ref-type="bibr">10</xref></sup> and have historically been reserved for cases recalcitrant to less invasive interventions.</p><p>Recently, novel surgical techniques have arisen from the need for a safe procedure with a benefit/risk profile acceptable for deployment earlier in the treatment sequence.<sup><xref rid="B11" ref-type="bibr">11</xref>&#x02013;<xref rid="B14" ref-type="bibr">14</xref></sup> These procedures as initially described had five distinct attributes: they were performed <italic>via</italic> an ab interno microincision; were minimally traumatic to both target and neighboring ocular tissues; delivered at least modest efficacy; had a favorable safety profile that avoided hypotony and bleb-related complications; and permitted rapid recovery, particularly with regard to visual acuity.<sup><xref rid="B15" ref-type="bibr">15</xref></sup> More recently, hybrid procedures have sought to bridge the gap between minimally invasive and more traditional procedures by utilizing subconjunctival filtration; these procedures deliver greater efficacy than TM-based procedures but are associated with bleb-related risks.<sup><xref rid="B11" ref-type="bibr">11</xref>&#x02013;<xref rid="B14" ref-type="bibr">14</xref></sup></p><p>The ever-expanding array of novel glaucoma surgeries and the growing body of literature make a full review of all procedures impractical. Further, as distinct efficacy and safety profiles are clarified, indications for the various procedures are diverging. This review focuses on excisional goniotomy performed using the KDB. The goal of this paper is to review the current status of the procedure, including its indication, surgical technique and instrumentation, efficacy and safety results, and its role in the surgical management of glaucoma.</p></sec><sec><title>The Kahook Dual Blade</title><p>The KDB was authorized for marketing by the United States Food and Drug Administration in 2015 <italic>via</italic> a 510(k) class I exemption as an ophthalmic knife<sup><xref rid="B16" ref-type="bibr">16</xref></sup> indicated to manually cut TM in pediatric and adult patients.<sup><xref rid="B17" ref-type="bibr">17</xref></sup> The instrument is a handheld knife designed to engage, stretch, and excise a strip of TM. The KDB features a specialized distal footplate consisting of a pointed tip that widens posteriorly, a ramp extending from the tip, and a pair of elevated parallel blades incorporated into the posterior aspect of the ramp (<xref rid="F1" ref-type="fig">Fig. 1</xref>). This design facilitates the excision procedure: the pointed tip engages and penetrates TM, the 230-micron wide footplate is seated in Schlemm's canal (the width of which is ~250 microns<sup><xref rid="B18" ref-type="bibr">18</xref>&#x02013;<xref rid="B20" ref-type="bibr">20</xref></sup>), and as the tip/footplate advances along the canal, the TM is put on stretch as it feeds up the ramp and encounters the dual blades which cleanly excise a strip of stretched TM. The angle of the distal cutting surface and the diameter of the device shaft are designed for maximum angle treatment through a single clear corneal incision.<sup><xref rid="B21" ref-type="bibr">21</xref></sup> In a laboratory experiment, the KDB demonstrated more complete TM removal than either a microvitreoretinal (MVR) blade or trabecular ablation using the Trabectome (Microsurgical Technology, Redmond, WA), with minimal residual leaflets of TM and no damage to neighboring tissues.<sup><xref rid="B22" ref-type="bibr">22</xref></sup> A histological analysis of excised TM strips from adult eyes with glaucoma confirmed the presence of TM in all samples,<sup><xref rid="B23" ref-type="bibr">23</xref></sup> in contrast to trabeculectomy in which up to 40% of cases do not excise TM.<sup><xref rid="B24" ref-type="bibr">24</xref></sup> A second-generation KDB instrument (KDB Glide, New World Medical) is in development that features beveled edges and rounded corners on the footplate to facilitate greater ease of passage along the canal while preserving ramp and blade dimensions and configuration. In a second laboratory experiment, the Glide produced more reliable TM excision than an MVR blade, 360&#x000b0;trabeculotomy with 5&#x02013;0 prolene suture, or the TrabEx device (Microsurgical Technology).<sup><xref rid="B25" ref-type="bibr">25</xref></sup></p><fig position="float" id="F1"><label>Fig. 1</label><caption><p>Left: Kahook Dual Blade. Right: second-generation KDB Glide. Center: highlighted differences between the two designs</p></caption><graphic xlink:href="jocgp-16-59-g001" position="float"/></fig></sec><sec><title>Surgical Technique</title><p>The KDB tip enters the anterior chamber through a temporal peripheral clear corneal incision and, under direct gonioscopic visualization, is advanced to the nasal TM. The instrument's sharp tip then engages TM, fashioning an opening through which the heel at the base of the footplate is seated in Schlemm's canal. The tip is then advanced within the canal along with the TM, which is elevated onto the ramp and stretched as it is guided to the two cutting blades that remove an intact TM strip. The strip is then removed from the eye with the KDB or with forceps. This elevation and stretching of the TM before excision maximizes the width of the excised strip and protects adjacent structures from collateral injury.<sup><xref rid="B17" ref-type="bibr">17</xref>,<xref rid="B21" ref-type="bibr">21</xref></sup> Three excisional approaches have been described:</p><list list-type="bullet"><list-item><p>Mark and meet: The KDB tip fashions an opening at one end of the planned strip of TM to be excised to mark the location and is then withdrawn from the TM. The tip then engages TM at the opposite end of the planned excision with the device tip pointed toward the initial TM opening and advanced until the strip between the two points is fully excised. A single tissue strip is excised.</p></list-item><list-item><p>Outside-in: The KDB tip engages TM at one end of the planned excision and is advanced to the approximate midpoint of the planned excision. The tip then engages TM at the opposite end of the planned excision and is advanced to meet the first pass at the midpoint. A single tissue strip is excised.</p></list-item><list-item><p>Inside-out: The KDB tip engages TM at the approximate center of the planned excision and is advanced to one end of the planned excision. The tip is then rotated 180&#x000b0; and reseated in the canal at the initial (central) point, then advanced to the opposite end of the planned excision. The two half-length tissue strips are either excised or remain in place according to surgeon preference.</p></list-item></list></sec></sec><sec sec-type="review results"><title>R<sc>eview</sc> R<sc>esults</sc></title><sec><title>Clinical Efficacy Outcomes</title><sec><title>Standalone vs Combined with Phacoemulsification</title><p>Excisional goniotomy with the KDB can be performed either as a standalone procedure or in combination with phacoemulsification in eyes with coexisting visually significant cataracts. It is important to consider the different indications and surgical goals likely applicable to these two scenarios. Standalone glaucoma procedures are typically performed in the setting of elevated IOP with the goal of lowering IOP; less commonly standalone surgery is performed to reduce the medication burden. Conversely, when combined with phacoemulsification, the surgical goal is usually to reduce the medication burden; less commonly, the need for visual rehabilitation and IOP reduction arise contemporaneously in eyes with coexisting cataracts and glaucoma. Outcomes in standalone vs combined surgeries are therefore presented separately and summarized in <xref rid="T1" ref-type="table">Table 1</xref>.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>IOP and medication reductions in standalone and combined procedures</p></caption><table frame="hsides" rules="groups" cellpadding="10" cellspacing="0"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1"/><th align="left" valign="middle" rowspan="1" colspan="1">
<italic>IOP reductions</italic>
</th><th align="left" valign="middle" rowspan="1" colspan="1">
<italic>Medication reductions</italic>
</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Standalone<sup><xref rid="B26" ref-type="bibr">26</xref>&#x02013;<xref rid="B31" ref-type="bibr">31</xref></sup></td><td align="center" valign="middle" rowspan="1" colspan="1">11&#x02013;36%</td><td align="center" valign="middle" rowspan="1" colspan="1">15&#x02013;92%<xref rid="TFN1-1" ref-type="table-fn">*</xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Combined<sup><xref rid="B21" ref-type="bibr">21</xref>,<xref rid="B29" ref-type="bibr">29</xref>&#x02013;<xref rid="B40" ref-type="bibr">40</xref>,<xref rid="B42" ref-type="bibr">42</xref></sup></td><td align="center" valign="middle" rowspan="1" colspan="1">11&#x02013;34%</td><td align="center" valign="middle" rowspan="1" colspan="1">11&#x02013;79%</td></tr></tbody></table><table-wrap-foot><fn id="TFN1-1"><p>*one study reported a 14% increase in medication use<sup><xref rid="B30" ref-type="bibr">30</xref></sup></p></fn></table-wrap-foot></table-wrap><p>Standalone: IOP and medication reductions following standalone surgery have been characterized in one prospective and five retrospective studies of 4&#x02013;18 months in duration.<sup><xref rid="B26" ref-type="bibr">26</xref>&#x02013;<xref rid="B31" ref-type="bibr">31</xref></sup> In these studies, mean IOP reductions of 11&#x02013;36% and mean medication reductions of 15&#x02013;92% (note: one study reported a medication increase of 14% at 18 months<sup><xref rid="B30" ref-type="bibr">30</xref></sup>) were reported. These wide ranges likely represent variable proportions of patients in each study undergoing surgery for IOP versus medication reductions.</p><p>Combined with phacoemulsification: Efficacy outcomes in samples composed chiefly of eyes with open-angle glaucoma undergoing combined surgery have been reported in one randomized clinical trial,<sup><xref rid="B32" ref-type="bibr">32</xref></sup> six retrospective controlled studies (one reported at two time points<sup><xref rid="B33" ref-type="bibr">33</xref>,<xref rid="B34" ref-type="bibr">34</xref></sup>),<sup><xref rid="B35" ref-type="bibr">35</xref>&#x02013;<xref rid="B39" ref-type="bibr">39</xref></sup> and seven retrospective uncontrolled studies [one reported at two time points<sup><xref rid="B26" ref-type="bibr">26</xref>,<xref rid="B40" ref-type="bibr">40</xref></sup>; another reported a pooled sample of primarily combined cases (90%)<sup><xref rid="B41" ref-type="bibr">41</xref></sup>].<sup><xref rid="B21" ref-type="bibr">21</xref>,<xref rid="B29" ref-type="bibr">29</xref>&#x02013;<xref rid="B31" ref-type="bibr">31</xref>,<xref rid="B42" ref-type="bibr">42</xref></sup> In these 17 reports with follow-up ranging from 4&#x02013;18 months, mean IOP reductions of 11&#x02013;34% and mean medication reductions of 11&#x02013;79% were described. These ranges were generally consistent across the various study designs with the exception of the randomized trial (17% IOP reduction, 79% medication reduction), which enrolled primarily patients with mild disease (79%) whose baseline IOP was quite low (18.5 mm Hg) suggesting medication reduction as the goal of surgery in most cases.<sup><xref rid="B32" ref-type="bibr">32</xref></sup> Importantly in eyes undergoing concurrent cataract surgery for visual rehabilitation, visual acuity outcomes were not compromised with the addition of excisional goniotomy with the KDB in the studies cited above, and the combined procedure was not associated with refractive surprise (<xref rid="T1" ref-type="table">Table 1</xref>).<sup><xref rid="B43" ref-type="bibr">43</xref></sup></p></sec><sec><title>Across the Spectrum of IOP</title><p>In an effort to better characterize patient-specific surgical goals, three investigative groups conducted subgroup analyzes stratifying subjects by baseline IOP above vs below the mean or median preoperative IOP, with the assumption being that patients with higher baseline IOP likely underwent surgery to achieve IOP reduction while those with lower baseline IOP more likely sought to achieve medication reduction.<sup><xref rid="B26" ref-type="bibr">26</xref>,<xref rid="B34" ref-type="bibr">34</xref>,<xref rid="B40" ref-type="bibr">40</xref></sup> As might be expected, IOP reductions were greater in eyes with higher baseline IOP than with lower baseline IOP, while medication reductions were generally similar in the two groups (<xref rid="T2" ref-type="table">Table 2</xref>).</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>IOP and medication reductions stratified by baseline IOP</p></caption><table frame="hsides" rules="groups" cellpadding="10" cellspacing="0"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1"/><th align="left" valign="middle" rowspan="1" colspan="1">
<italic>IOP reductions</italic>
</th><th align="left" valign="middle" rowspan="1" colspan="1">
<italic>Medication reductions</italic>
</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Low baseline IOP<sup><xref rid="B26" ref-type="bibr">26</xref>,<xref rid="B34" ref-type="bibr">34</xref>,<xref rid="B40" ref-type="bibr">40</xref></sup></td><td align="center" valign="middle" rowspan="1" colspan="1">4&#x02013;21%</td><td align="center" valign="middle" rowspan="1" colspan="1">36&#x02013;61%</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">High baseline IOP<sup><xref rid="B26" ref-type="bibr">26</xref>,<xref rid="B34" ref-type="bibr">34</xref>,<xref rid="B40" ref-type="bibr">40</xref></sup></td><td align="center" valign="middle" rowspan="1" colspan="1">40&#x02013;46%</td><td align="center" valign="middle" rowspan="1" colspan="1">33&#x02013;84%</td></tr></tbody></table></table-wrap></sec><sec><title>Across the Spectrum of Glaucoma Severity</title><p>While no study to date has reported outcomes stratified by baseline glaucoma severity, differences in the severity of glaucoma between study samples permit some inference on this point. A caveat of this approach is that the method of classifying glaucoma severity was not always described and may differ between studies. Eight studies had KDB groups with predominantly (&#x02265;75%) mild-moderate glaucoma<sup><xref rid="B26" ref-type="bibr">26</xref>,<xref rid="B27" ref-type="bibr">27</xref>,<xref rid="B32" ref-type="bibr">32</xref>,<xref rid="B33" ref-type="bibr">33</xref>,<xref rid="B36" ref-type="bibr">36</xref></sup> or moderate-severe glaucoma.<sup><xref rid="B28" ref-type="bibr">28</xref>,<xref rid="B37" ref-type="bibr">37</xref>,<xref rid="B42" ref-type="bibr">42</xref></sup> Both IOP and medication reductions were similar in studies at both ends of the severity spectrum (<xref rid="T3" ref-type="table">Table 3</xref>).</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>IOP and medication reductions stratified by severity of glaucoma at baseline</p></caption><table frame="hsides" rules="groups" cellpadding="10" cellspacing="0"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1"/><th align="left" valign="middle" rowspan="1" colspan="1">
<italic>IOP reductions</italic>
</th><th align="left" valign="middle" rowspan="1" colspan="1">
<italic>Medication reductions</italic>
</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Mild-moderate (&#x0003e;75% of eyes with mild-moderate disease)<sup><xref rid="B26" ref-type="bibr">26</xref>,<xref rid="B27" ref-type="bibr">27</xref>,<xref rid="B32" ref-type="bibr">32</xref>,<xref rid="B33" ref-type="bibr">33</xref>,<xref rid="B36" ref-type="bibr">36</xref></sup></td><td align="center" valign="middle" rowspan="1" colspan="1">14&#x02013;36%</td><td align="center" valign="middle" rowspan="1" colspan="1">15&#x02013;79%</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Moderate-severe (&#x0003e;75% of eyes with moderate-severe disease)<sup><xref rid="B28" ref-type="bibr">28</xref>,<xref rid="B37" ref-type="bibr">37</xref>,<xref rid="B42" ref-type="bibr">42</xref></sup></td><td align="center" valign="middle" rowspan="1" colspan="1">12&#x02013;26%</td><td align="center" valign="middle" rowspan="1" colspan="1">36&#x02013;50%</td></tr></tbody></table></table-wrap></sec></sec><sec><title>In Comparison to Other Procedures</title><p>One randomized trial<sup><xref rid="B32" ref-type="bibr">32</xref></sup> and five retrospective studies<sup><xref rid="B33" ref-type="bibr">33</xref>&#x02013;<xref rid="B37" ref-type="bibr">37</xref></sup> have compared excisional goniotomy to trabecular micro bypass implantation (iStent, Glaukos, San Clemente, CA) when each was combined with phacoemulsification. In the randomized trial, 164 eyes with mild to moderate open-angle glaucoma (OAG) were randomized to one of the two treatments.<sup><xref rid="B32" ref-type="bibr">32</xref></sup> The study's primary endpoint was IOP reduction &#x02265;20% or IOP reduction &#x02265;1 medication at 12 months and was achieved by 94% of excisional goniotomy eyes and 83% of micro bypass eyes (<italic>p</italic> = 0.04). At 12 months, mean IOP reductions were 17% in the excisional goniotomy group and 13% in the micro bypass group, while medication reductions were 79% and 70%, respectively; differences were statistically significant. Among the five retrospective studies, mean IOP reductions ranged from 13&#x02013;27% for excisional goniotomy and 13&#x02013;19% for micro bypass implantation [differences significant (<italic>p</italic> &#x0003c; 0.05) in three studies, insignificant in the remaining two], while medication reductions ranged from 27&#x02013;79% and 6&#x02013;70%, respectively (differences significant favoring KDB in two studies, micro bypass in one study, and insignificant in two studies) (<xref rid="T4" ref-type="table">Table 4</xref>). Retrospective comparative studies such as these must be interpreted with great caution, as physicians selected the procedure they felt was best for each patient at the time of surgery, and thus the patient characteristics of each treatment group may differ in important ways. This is illustrated in one of the retrospective studies cited above,<sup><xref rid="B37" ref-type="bibr">37</xref></sup> in which 58% of eyes undergoing excisional goniotomy had severe glaucoma at baseline while 0% of micro bypass eyes had severe glaucoma at baseline. While this reveals a clear bias on the investigators&#x02019; part for excisional goniotomy in eyes with more severe glaucoma, it underscores the challenges of retrospective comparisons: in this case, significantly greater medication reductions were seen in micro bypass eyes (59% vs 36%, <italic>p</italic> &#x0003c; 0.01), but the patient characteristics suggest that far more micro bypass eyes underwent surgery at an earlier disease stage and may have preferentially sought medication reduction compared to the excisional goniotomy eyes that underwent surgery at a later stage and likely sought IOP reduction (which was greater in excisional goniotomy eyes&#x02014;26% vs 19%, <italic>p</italic> = 0.03). There may also be differences in the nature of surgical failure between these two procedures. A study of TM tissue changes in three eyes undergoing micro bypass explanation for surgical failure revealed loss of TM cells, the collapse of collagen beams, an increase in fibrous material, and a basement membrane-like structure that were not seen in unimplanted glaucomatous or healthy eyes.<sup><xref rid="B44" ref-type="bibr">44</xref></sup></p><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>IOP and medication reductions in comparative studies of excisional goniotomy with the KDB</p></caption><table frame="hsides" rules="groups" cellpadding="10" cellspacing="0"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1"/><th colspan="2" align="center" valign="middle" rowspan="1">
<italic>IOP reductions</italic>
</th><th colspan="2" align="center" valign="middle" rowspan="1">
<italic>Medication reductions</italic>
</th></tr><tr><th align="left" valign="middle" rowspan="1" colspan="1">
<italic>Comparator</italic>
</th><th align="center" valign="middle" rowspan="1" colspan="1">
<italic>KDB</italic>
</th><th align="center" valign="middle" rowspan="1" colspan="1">
<italic>Comparator</italic>
</th><th align="center" valign="middle" rowspan="1" colspan="1">
<italic>KDB</italic>
</th><th align="center" valign="middle" rowspan="1" colspan="1">
<italic>Comparator</italic>
</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Trabecular microbypass<sup><xref rid="B32" ref-type="bibr">32</xref>&#x02013;<xref rid="B37" ref-type="bibr">37</xref></sup></td><td align="center" valign="middle" rowspan="1" colspan="1">13&#x02013;27%</td><td align="center" valign="middle" rowspan="1" colspan="1">13&#x02013;19%</td><td align="center" valign="middle" rowspan="1" colspan="1">27&#x02013;79%</td><td align="center" valign="middle" rowspan="1" colspan="1">6&#x02013;70%</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">360&#x000b0;trabeculotomy<sup><xref rid="B38" ref-type="bibr">38</xref></sup></td><td align="center" valign="middle" rowspan="1" colspan="1">13%</td><td align="center" valign="middle" rowspan="1" colspan="1">6%</td><td align="center" valign="middle" rowspan="1" colspan="1">45%</td><td align="center" valign="middle" rowspan="1" colspan="1">58%</td></tr></tbody></table></table-wrap><p>A single study reported a retrospective comparison of excisional goniotomy with 360&#x000b0;trabeculotomy performed either <italic>via</italic> gonioscopy-assisted transluminal trabeculotomy or using the TRAB360 device (Sight Sciences, Menlo Park, CA) in eyes with primarily severe OAG.<sup><xref rid="B38" ref-type="bibr">38</xref></sup> At 6 months postoperatively, mean IOP reductions were 13% in excisional goniotomy eyes and 6% in eyes undergoing 360&#x000b0;trabeculotomy (<italic>p</italic> = ns). More eyes undergoing excisional goniotomy than 360&#x000b0;trabeculotomy achieved final IOP &#x0003c;18 mm Hg (80% vs 59%, <italic>p</italic> = 0.04) and &#x0003c;15 mm Hg 61% vs 26%, <italic>p</italic> = 0.003) (<xref rid="T4" ref-type="table">Table 4</xref>).</p></sec><sec><title>In Other Forms of Glaucoma</title><p>Angle Closure Glaucoma: The application of angle-based surgery in an eye with angle-closure glaucoma (ACG) is not immediately intuitive. However, paired with goniosynechialysis (also performed with the KDB), excisional goniotomy has been shown to provide substantial reductions in both IOP and the need for IOP-lowering medications. A series of 42 eyes of a mixed ethnicity sample (half of whom were Asian) underwent combined phacoemulsification, goniosynechialysis, and excisional goniotomy with the KDB has been reported at 6,<sup><xref rid="B45" ref-type="bibr">45</xref></sup> 12,<sup><xref rid="B46" ref-type="bibr">46</xref></sup> and 24<sup><xref rid="B47" ref-type="bibr">47</xref></sup> months postoperatively. Initial IOP reductions of 49% and medication reductions of 92% persisted through 12 months (47% and 92%, respectively) and 24 months (47% and 76%, respectively). At 24 months, 95% of eyes achieved IOP &#x02264;18 mm Hg, 100% had IOP reductions &#x02265;20% from baseline, 86% were on fewer medications than at baseline, and 69% were medication-free.<sup><xref rid="B47" ref-type="bibr">47</xref></sup> The investigators explained their rationale for the combined procedure by pointing out that TM dysfunction can occur in eyes with ACG and thus opening the angle alone may not fully address outflow obstruction; coupling excisional goniotomy to the cataract extraction and goniosynechialysis procedures removes potentially dysfunctional TM and optimizes aqueous outflow through the TM outflow pathway.<sup><xref rid="B47" ref-type="bibr">47</xref></sup></p><p>Uveitic Glaucoma: A series of 16 eyes with glaucoma associated with uveitis undergoing excisional goniotomy with the KDB either as a standalone procedure or in combination with phacoemulsification has been reported.<sup><xref rid="B48" ref-type="bibr">48</xref></sup> Patients in this series were younger than in studies of primary open-angle glaucoma (POAG) (mean age 43 years) and had a wide variety of underlying inflammatory ocular conditions underlying their uveitis. Survival analysis revealed a 68% 1-year success rate at achieving prespecified and patient-specific target IOP. Mean IOP was 28.1 mm Hg preoperatively and at last follow-up (mean 9.6 months) was 17.4 (<italic>p</italic> = 0.007); medication use was reduced from a mean of 3.6 preoperatively to 2.1 at last follow-up (<italic>p</italic> = 0.004).</p><p>Childhood Glaucoma: Several case reports have demonstrated the utility of excisional goniotomy using the KDB in the eyes of children with developmental glaucomas. In an infant with bilateral glaucoma, IOP was reduced from 35 mm Hg and 52 mm Hg to 17 mm Hg and 18 mm Hg in right and left eyes, respectively.<sup><xref rid="B49" ref-type="bibr">49</xref></sup> In a similar report, IOP was reduced from &#x02212;21 mm Hg in the right eye of an infant but failed to lower IOP in the left eye following three excisional goniotomy procedures necessitating implantation of a tube-shunt.<sup><xref rid="B50" ref-type="bibr">50</xref></sup> In a 14-year-old with juvenile OAG, mean IOP was reduced from 28&#x02013;15 mm Hg.<sup><xref rid="B51" ref-type="bibr">51</xref></sup></p><p>Other Glaucomas: In a case of steroid-related IOP elevation following penetrating keratoplasty, excisional goniotomy with the KDB lowered IOP from 32&#x02013;13 mm Hg.<sup><xref rid="B52" ref-type="bibr">52</xref></sup> In a case of glaucoma associated with transthyretin amyloidosis, IOP was lowered from 32 to &#x0003c; 14 mm Hg.<sup><xref rid="B53" ref-type="bibr">53</xref></sup></p></sec><sec><title>Clinical Safety Outcomes</title><p>Excisional goniotomy with the KDB is generally a safe procedure without significant sight-threatening complications. Transient bleeding from the TM excision site is common, expected, and typical of most angle-based surgeries. The most common adverse event across the various studies was IOP elevation, occurring in 3&#x02013;32% of eyes.<sup><xref rid="B21" ref-type="bibr">21</xref>,<xref rid="B29" ref-type="bibr">29</xref>,<xref rid="B32" ref-type="bibr">32</xref>,<xref rid="B33" ref-type="bibr">33</xref>,<xref rid="B36" ref-type="bibr">36</xref>,<xref rid="B37" ref-type="bibr">37</xref>,<xref rid="B39" ref-type="bibr">39</xref>,<xref rid="B40" ref-type="bibr">40</xref></sup> This may be attributable in part to a steroid response, although specific mechanisms remain elusive. The highest reported incidence in this range&#x02014;32%, occurred in the randomized trial vs the micro bypass. In these eyes, the incidence of IOP elevations was 33%.<sup><xref rid="B32" ref-type="bibr">32</xref></sup> Among the retrospective comparisons of excisional goniotomy and micro bypass, IOP elevations were seen in 13&#x02013;18% of the former and 2&#x02013;7% of the latter.<sup><xref rid="B33" ref-type="bibr">33</xref>,<xref rid="B36" ref-type="bibr">36</xref>,<xref rid="B37" ref-type="bibr">37</xref></sup> Transient pain was reported in 8% of eyes in one study.<sup><xref rid="B40" ref-type="bibr">40</xref></sup> Also in the randomized trial the rates of posterior capsule opacification were 9% in incisional goniotomy eyes and 6% in micro bypass eyes.<sup><xref rid="B32" ref-type="bibr">32</xref></sup></p><p>Unlike other glaucoma procedures, excisional goniotomy does not require the implantation of a device, obviating secondary surgical procedures for device-related complications, and does not create a bleb, precluding the need for suture lysis, needling, and other routine postoperative bleb management procedures. Instead, reoperations following excisional goniotomy are necessitated by surgical failure. In the various studies cited above, the reoperation rate for surgical failure following excisional goniotomy ranged from 2&#x02013;22%, with a trend toward higher reoperation rates in studies (and in patients within studies) with more severe glaucoma and/or higher baseline IOP.<sup><xref rid="B27" ref-type="bibr">27</xref>,<xref rid="B28" ref-type="bibr">28</xref>,<xref rid="B30" ref-type="bibr">30</xref>,<xref rid="B37" ref-type="bibr">37</xref>,<xref rid="B41" ref-type="bibr">41</xref>,<xref rid="B42" ref-type="bibr">42</xref></sup> The common complications of the procedure are summarized in <xref rid="T5" ref-type="table">Table 5</xref>.</p><table-wrap position="float" id="T5"><label>Table 5</label><caption><p>Complications associated with excisional goniotomy</p></caption><table frame="hsides" rules="groups" cellpadding="10" cellspacing="0"><thead><tr><th align="center" valign="top" rowspan="1" colspan="1">
<italic>Complications</italic>
</th><th align="center" valign="middle" rowspan="1" colspan="1">
<italic>Reported Incidence (%)</italic>
</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Elevated intraocular pressure</td><td align="left" valign="top" rowspan="1" colspan="1">3&#x02013;32%<sup><xref rid="B21" ref-type="bibr">21</xref>,<xref rid="B29" ref-type="bibr">29</xref>,<xref rid="B32" ref-type="bibr">32</xref>,<xref rid="B33" ref-type="bibr">33</xref>,<xref rid="B36" ref-type="bibr">36</xref>,<xref rid="B37" ref-type="bibr">37</xref>,<xref rid="B39" ref-type="bibr">39</xref>,<xref rid="B40" ref-type="bibr">40</xref></sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Posterior capsule opacification (combined surgery)</td><td align="left" valign="top" rowspan="1" colspan="1">9%<sup><xref rid="B32" ref-type="bibr">32</xref></sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Transient pain</td><td align="left" valign="top" rowspan="1" colspan="1">8%<sup><xref rid="B40" ref-type="bibr">40</xref></sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Reoperation rate</td><td align="left" valign="top" rowspan="1" colspan="1">2&#x02013;22%<sup><xref rid="B27" ref-type="bibr">27</xref>,<xref rid="B28" ref-type="bibr">28</xref>,<xref rid="B30" ref-type="bibr">30</xref>,<xref rid="B37" ref-type="bibr">37</xref>&#x02013;<xref rid="B39" ref-type="bibr">39</xref>,<xref rid="B41" ref-type="bibr">41</xref></sup></td></tr></tbody></table></table-wrap></sec></sec><sec sec-type="discussion"><title>D<sc>iscussion</sc></title><sec><title>Considerations for Patient Selection</title><p>Given the vast array of new and traditional glaucoma procedures available today, a clear understanding of each procedure's features and limitations is essential in selecting the best procedure for each individual patient. Key features to consider when planning surgery include a procedure's indication, efficacy in the context of patient-specific surgical goals, safety including the rapidity of visual rehabilitation, ease of performance, and ability to pair with concurrent procedures, among others.</p><p>As discussed above the KDB instrument and not the procedure itself is regulated. Thus, the clinical indications of the procedure are determined by efficacy and safety profiles in various clinical settings. Multiple studies described in this review demonstrate the efficacy and safety of excisional goniotomy with the KDB in eyes with OAG across the spectrum of disease severity and baseline IOP. Further, its clinical utility has been demonstrated in eyes with angle-closure glaucoma, uveitic glaucoma, glaucomas of childhood, and other forms of glaucoma.</p><p>Patient-specific surgical goals may be IOP reduction, medication reduction, or both. Substantial medication reductions have been reported across the spectrum of baseline IOP and disease severity, and in eyes with high baseline IOP, IOP reductions of 40&#x02013;46% with excisional goniotomy are on the order of those delivered by trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (44&#x02013;48%) without the attendant life-long risk of bleb-related complications.<sup><xref rid="B54" ref-type="bibr">54</xref></sup></p><p>The procedure is straightforward to perform,<sup><xref rid="B21" ref-type="bibr">21</xref></sup> offers versatility as a standalone procedure or in combination with cataract surgery and has a favorable safety profile with rapid visual recovery and no refractive surprise. Clinical scenarios in which excisional goniotomy is contraindicated are given in <xref rid="T6" ref-type="table">Table 6</xref>.</p><table-wrap position="float" id="T6"><label>Table 6</label><caption><p>Contraindications to excisional goniotomy</p></caption><table frame="hsides" rules="groups" cellpadding="10" cellspacing="0"><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">
<italic>Contraindications</italic>
</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Active uveitis</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Neovascular glaucoma</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Acute angle closure glaucoma</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Corneal opacity precluding angle visualization</td></tr></tbody></table></table-wrap></sec></sec><sec sec-type="conclusion"><title>C<sc>onclusion</sc></title><p>In summary, excisional goniotomy with the KDB effectively lowers IOP and reduces the medication burden in eyes with POAG and other forms of glaucoma across the spectrum of both baseline IOP and disease severity. The procedure exhibits a safety profile that is on par with other angle-based surgical interventions and enhanced safety compared to filtration procedures. It can be performed by comprehensive ophthalmologists as well as glaucoma specialists. This procedure as a standalone operation delivers IOP reductions consistent with filtration surgery, and in combination with cataract surgery delivers both IOP and medication reductions at least as great as other minimally invasive procedures. Given the broad base of evidence supporting its use in a wide variety of clinical scenarios, excisional goniotomy with the KDB can play a meaningful role in the achievement of patient-specific glaucoma therapy goals.</p></sec><sec sec-type="clinical significance"><title>C<sc>linical</sc> S<sc>ignificance</sc></title><p>These aggregate findings support the efficacy and safety of excisional goniotomy with the KDB in a broad array of clinical scenarios and clarify the patient profiles best suited for this procedure.</p></sec></body><back><ack><title>A<sc>cknowledgments</sc></title><p>The authors wish to acknowledge Tony Realini, MD, MPH, for assistance in preparing this manuscript.</p><p>Support for manuscript preparation assistance was provided by New World Medical.</p></ack><fn-group><fn id="fn1" fn-type="COI-statement"><p><bold>Source of support:</bold> Nil</p><p><bold>Conflict of interest:</bold> None</p></fn></fn-group><ref-list><title>R<sc>eferences</sc></title><ref id="B1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barkan</surname><given-names>O</given-names></name></person-group><article-title>A new operation for chronic glaucoma.</article-title><source>Am J Ophthalmol</source><year>1936</year><volume>19</volume><issue>11</issue><fpage>951</fpage><lpage>966</lpage><pub-id pub-id-type="doi">10.1016/S0002-9394(36)93838-2</pub-id></element-citation></ref><ref id="B2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>TD</given-names></name></person-group><article-title>Congenital glaucoma and cataract, bilateral; goniotomy and needling: case report.</article-title><source>Trans Am Ophthalmol Soc</source><year>1944</year><volume>42</volume><issue>4</issue><fpage>308</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1016/0002-9394(45)90943-3</pub-id><pub-id pub-id-type="pmid">16693354</pub-id></element-citation></ref><ref id="B3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheie</surname><given-names>HG</given-names></name></person-group><article-title>Goniotomy and the treatment of congenital glaucoma.</article-title><source>Am J Ophthalmol</source><year>1950</year><volume>33</volume><fpage>977</fpage><lpage>979</lpage><pub-id pub-id-type="pmid">15419237</pub-id></element-citation></ref><ref id="B4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheie</surname><given-names>HG</given-names></name></person-group><article-title>Goniotomy in the treatment of congenital glaucoma.</article-title><source>Arch Ophthalmol</source><year>1949</year><volume>42</volume><issue>3</issue><fpage>115</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1001/archopht.1949.00900050272005</pub-id></element-citation></ref><ref id="B5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barkan</surname><given-names>O</given-names></name></person-group><article-title>Present status of goniotomy.</article-title><source>Am J Ophthalmol</source><year>1953</year><volume>36</volume><issue>4</issue><fpage>445</fpage><lpage>453</lpage><pub-id pub-id-type="doi">10.1016/0002-9394(53)90555-8</pub-id><pub-id pub-id-type="pmid">13030655</pub-id></element-citation></ref><ref id="B6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>RA</given-names></name><name><surname>Baerveldt</surname><given-names>G</given-names></name><name><surname>Ozler</surname><given-names>SA</given-names></name><etal>et al.</etal></person-group><article-title>Laser trabecular ablation (LTA).</article-title><source>Lasers Surg Med</source><year>1991</year><volume>11</volume><issue>4</issue><fpage>341</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1002/lsm.1900110405</pub-id><pub-id pub-id-type="pmid">1654485</pub-id></element-citation></ref><ref id="B7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epstein</surname><given-names>DL</given-names></name><name><surname>Melamed</surname><given-names>S</given-names></name><name><surname>Puliafto</surname><given-names>CA</given-names></name><etal>et al.</etal></person-group><article-title>Neodymium: YAG laser trabeculopuncture in open-angle glaucoma.</article-title><source>Ophthalmology</source><year>1985</year><volume>92</volume><issue>7</issue><fpage>931</fpage><lpage>937</lpage><pub-id pub-id-type="doi">10.1016/s0161-6420(85)33932-5</pub-id><pub-id pub-id-type="pmid">4022580</pub-id></element-citation></ref><ref id="B8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobi</surname><given-names>PC</given-names></name><name><surname>Dietlein</surname><given-names>TS</given-names></name><name><surname>Krieglstein</surname><given-names>GK</given-names></name></person-group><article-title>Technique of goniocurettage: a potential treatment for advanced chronic open angle glaucoma.</article-title><source>Br J Ophthalmol</source><year>1997</year><volume>81</volume><issue>4</issue><fpage>302</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1136/bjo.81.4.302</pub-id><pub-id pub-id-type="pmid">9215060</pub-id></element-citation></ref><ref id="B9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gedde</surname><given-names>SJ</given-names></name><name><surname>Herndon</surname><given-names>LW</given-names></name><name><surname>Brandt</surname><given-names>JD</given-names></name><etal>et al.</etal></person-group><article-title>Surgical complications in the Tube Versus Trabeculectomy Study during the first year of follow-up.</article-title><source>Am J Ophthalmol</source><year>2007</year><volume>143</volume><issue>1</issue><fpage>23</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.ajo.2006.07.022</pub-id><pub-id pub-id-type="pmid">17054896</pub-id></element-citation></ref><ref id="B10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gedde</surname><given-names>SJ</given-names></name><name><surname>Herndon</surname><given-names>LW</given-names></name><name><surname>Brandt</surname><given-names>JD</given-names></name><etal>et al.</etal></person-group><article-title>Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.</article-title><source>Am J Ophthalmol</source><year>2012</year><volume>153</volume><issue>5</issue><fpage>804</fpage><lpage>814</lpage><pub-id pub-id-type="doi">10.1016/j.ajo.2011.10.024</pub-id><pub-id pub-id-type="pmid">22244522</pub-id></element-citation></ref><ref id="B11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richter</surname><given-names>GM</given-names></name><name><surname>Coleman</surname><given-names>AL</given-names></name></person-group><article-title>Minimally invasive glaucoma surgery: current status and future prospects.</article-title><source>Clin Ophthalmol</source><year>2016</year><volume>10</volume><fpage>189</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.2147/OPTH.S80490</pub-id><pub-id pub-id-type="pmid">26869753</pub-id></element-citation></ref><ref id="B12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavia</surname><given-names>C</given-names></name><name><surname>Dallorto</surname><given-names>L</given-names></name><name><surname>Maule</surname><given-names>M</given-names></name><etal>et al.</etal></person-group><article-title>Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: A systematic review and meta-analysis.</article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><issue>8</issue><fpage>e0183142</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0183142</pub-id><pub-id pub-id-type="pmid">28850575</pub-id></element-citation></ref><ref id="B13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pillunat</surname><given-names>LE</given-names></name><name><surname>Erb</surname><given-names>C</given-names></name><name><surname>Junemann</surname><given-names>AG</given-names></name><etal>et al.</etal></person-group><article-title>Micro-invasive glaucoma surgery (MIGS): a review of surgical procedures using stents.</article-title><source>Clin Ophthalmol</source><year>2017</year><volume>11</volume><fpage>1583</fpage><lpage>1600</lpage><pub-id pub-id-type="doi">10.2147/OPTH.S135316</pub-id><pub-id pub-id-type="pmid">28919702</pub-id></element-citation></ref><ref id="B14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>DZ</given-names></name><name><surname>Sng</surname><given-names>CCA</given-names></name></person-group><article-title>Safety and efficacy of microinvasive glaucoma surgery.</article-title><source>J Ophthalmol</source><year>2017</year><volume>2017</volume><fpage>3182935</fpage><pub-id pub-id-type="doi">10.1155/2017/3182935</pub-id><pub-id pub-id-type="pmid">28512578</pub-id></element-citation></ref><ref id="B15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saheb</surname><given-names>H</given-names></name><name><surname>Ahmed,</surname><given-names>II</given-names></name></person-group><article-title>Micro-invasive glaucoma surgery: current perspectives and future directions.</article-title><source>Curr Opin Ophthalmol</source><year>2012</year><volume>23</volume><issue>2</issue><fpage>96</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1097/ICU.0b013e32834ff1e7</pub-id><pub-id pub-id-type="pmid">22249233</pub-id></element-citation></ref><ref id="B16"><label>16.</label><element-citation publication-type="webpage"><comment>21CFR886.4350. 2019. (Accessed 8/18/2020, at</comment><uri xlink:href="https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=886.4350">https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=886.4350</uri><comment>.)</comment></element-citation></ref><ref id="B17"><label>17.</label><element-citation publication-type="journal"><collab>New World Medical, Inc.</collab><comment>Kahook Dual Blade. Instructions for Use. Rancho Cucamonga, CA,</comment><year>2018</year></element-citation></ref><ref id="B18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><etal>et al.</etal></person-group><article-title>Schlemm's canal and trabecular meshwork in eyes with primary open angle glaucoma: a comparative study using high-frequency ultrasound biomicroscopy.</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><issue>1</issue><fpage>e0145824</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0145824</pub-id><pub-id pub-id-type="pmid">26726880</pub-id></element-citation></ref><ref id="B19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>G</given-names></name><name><surname>Fu</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><etal>et al.</etal></person-group><article-title>Morphological changes in Schlemm's canal in treated and newly diagnosed untreated glaucomatous eyes.</article-title><source>Sci China Life Sci</source><year>2014</year><volume>57</volume><issue>12</issue><fpage>1213</fpage><lpage>1217</lpage><pub-id pub-id-type="doi">10.1007/s11427-014-4732-0</pub-id><pub-id pub-id-type="pmid">25218823</pub-id></element-citation></ref><ref id="B20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dietlein</surname><given-names>TS</given-names></name><name><surname>Jacobi</surname><given-names>PC</given-names></name><name><surname>Luke</surname><given-names>C</given-names></name><etal>et al.</etal></person-group><article-title>Morphological variability of the trabecular meshwork in glaucoma patients: implications for non-perforating glaucoma surgery.</article-title><source>Br J Ophthalmol</source><year>2000</year><volume>84</volume><issue>12</issue><fpage>1354</fpage><lpage>1359</lpage><pub-id pub-id-type="doi">10.1136/bjo.84.12.1354</pub-id><pub-id pub-id-type="pmid">11090472</pub-id></element-citation></ref><ref id="B21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenwood</surname><given-names>MD</given-names></name><name><surname>Seibold</surname><given-names>LK</given-names></name><name><surname>Radcliffe</surname><given-names>NM</given-names></name><etal>et al.</etal></person-group><article-title>Goniotomy with a single-use dual blade: short-term results.</article-title><source>JCataract Refract Surg</source><year>2017</year><volume>43</volume><issue>9</issue><fpage>1197</fpage><lpage>1201</lpage><pub-id pub-id-type="doi">10.1016/j.jcrs.2017.06.046</pub-id><pub-id pub-id-type="pmid">28991617</pub-id></element-citation></ref><ref id="B22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seibold</surname><given-names>LK</given-names></name><name><surname>Soohoo</surname><given-names>JR</given-names></name><name><surname>Ammar</surname><given-names>DA</given-names></name><etal>et al.</etal></person-group><article-title>Preclinical investigation of ab interno trabeculectomy using a novel dual-blade device.</article-title><source>Am J Ophthalmol</source><year>2013</year><volume>155</volume><issue>3</issue><fpage>524</fpage><lpage>529.e2</lpage><pub-id pub-id-type="doi">10.1016/j.ajo.2012.09.023</pub-id><pub-id pub-id-type="pmid">23218696</pub-id></element-citation></ref><ref id="B23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swaminathan</surname><given-names>SS</given-names></name><name><surname>Monsalve</surname><given-names>P</given-names></name><name><surname>Zhou</surname><given-names>XY</given-names></name><etal>et al.</etal></person-group><article-title>Histologic analysis of trabecular meshwork obtained from Kahook Dual Blade goniotomy.</article-title><source>Am J Ophthalmol</source><year>2018</year><volume>192</volume><fpage>198</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1016/j.ajo.2018.05.028</pub-id><pub-id pub-id-type="pmid">29883587</pub-id></element-citation></ref><ref id="B24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castelbuono</surname><given-names>AC</given-names></name><name><surname>Green</surname><given-names>WR</given-names></name></person-group><article-title>Histopathologic features of trabeculectomy surgery.</article-title><source>Trans Am Ophthalmol Soc</source><year>2003</year><volume>101</volume><fpage>119</fpage><lpage>124</lpage><comment>discussion 24&#x02013;5</comment><pub-id pub-id-type="pmid">14971570</pub-id></element-citation></ref><ref id="B25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ammar</surname><given-names>DA</given-names></name><name><surname>Seibold</surname><given-names>LK</given-names></name><name><surname>Kahook</surname><given-names>M</given-names></name></person-group><article-title>Preclinical investigation of ab interno goniotomy using four different techniques.</article-title><source>Clin Ophthalmol</source><year>2020</year><volume>14</volume><fpage>3519</fpage><lpage>3525</lpage><pub-id pub-id-type="doi">10.2147/OPTH.S281811</pub-id><pub-id pub-id-type="pmid">33149545</pub-id></element-citation></ref><ref id="B26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berdahl</surname><given-names>JP</given-names></name><name><surname>Gallardo</surname><given-names>MJ</given-names></name><name><surname>ElMallah</surname><given-names>MK</given-names></name><etal>et al.</etal></person-group><article-title>Six-month outcomes of goniotomy performed with the Kahook Dual Blade as a stand-alone glaucoma procedure.</article-title><source>Adv Ther</source><year>2018</year><volume>35</volume><issue>11</issue><fpage>2093</fpage><lpage>2102</lpage><pub-id pub-id-type="doi">10.1007/s12325-018-0803-0</pub-id><pub-id pub-id-type="pmid">30317414</pub-id></element-citation></ref><ref id="B27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>ElMallah</surname><given-names>MK</given-names></name><name><surname>Berdahl</surname><given-names>JP</given-names></name><name><surname>Williamson</surname><given-names>BK</given-names></name><etal>et al.</etal></person-group><article-title>Twelve-month outcomes of stand-alone excisional goniotomy in mild to severe glaucoma.</article-title><source>Clin Ophthalmol</source><year>2020</year><volume>14</volume><fpage>1891</fpage><lpage>1897</lpage><pub-id pub-id-type="doi">10.2147/OPTH.S256423</pub-id><pub-id pub-id-type="pmid">32694910</pub-id></element-citation></ref><ref id="B28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salinas</surname><given-names>L</given-names></name><name><surname>Chaudhary</surname><given-names>A</given-names></name><name><surname>Berdahl</surname><given-names>JP</given-names></name><etal>et al.</etal></person-group><article-title>Goniotomy using the Kahook Dual Blade in severe and refractory glaucoma: 6-month outcomes.</article-title><source>J Glaucoma</source><year>2018</year><volume>27</volume><issue>10</issue><fpage>849</fpage><lpage>855</lpage><pub-id pub-id-type="doi">10.1097/IJG.0000000000001019</pub-id><pub-id pub-id-type="pmid">29979337</pub-id></element-citation></ref><ref id="B29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sieck</surname><given-names>EG</given-names></name><name><surname>Epstein</surname><given-names>RS</given-names></name><name><surname>Kennedy</surname><given-names>JB</given-names></name><etal>et al.</etal></person-group><article-title>Outcomes of Kahook Dual Blade goniotomy with and without phacoemulsification cataract extraction.</article-title><source>Ophthalmology Glaucoma</source><year>2018</year><volume>1</volume><issue>1</issue><fpage>75</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1016/j.ogla.2018.06.006</pub-id><pub-id pub-id-type="pmid">32672636</pub-id></element-citation></ref><ref id="B30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wakil</surname><given-names>SM</given-names></name><name><surname>Birnbaum</surname><given-names>F</given-names></name><name><surname>Vu</surname><given-names>DM</given-names></name><etal>et al.</etal></person-group><article-title>Efficacy and safety of Kahook Dual Blade goniotomy: 18-month results.</article-title><source>J Cataract Refract Surg</source><year>2020</year><volume>46</volume><issue>10</issue><fpage>1408</fpage><lpage>1415</lpage><pub-id pub-id-type="doi">10.1097/j.jcrs.0000000000000263</pub-id><pub-id pub-id-type="pmid">32483073</pub-id></element-citation></ref><ref id="B31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barry</surname><given-names>M</given-names></name><name><surname>Alahmadi</surname><given-names>MW</given-names></name><name><surname>Alahmadi</surname><given-names>M</given-names></name><etal>et al.</etal></person-group><article-title>The safety of the Kahook Dual Blade in the surgical treatment of glaucoma.</article-title><source>Cureus</source><year>2020</year><volume>12</volume><issue>1</issue><fpage>e6682</fpage><pub-id pub-id-type="doi">10.7759/cureus.6682</pub-id><pub-id pub-id-type="pmid">31976190</pub-id></element-citation></ref><ref id="B32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falkenberry</surname><given-names>S</given-names></name><name><surname>Singh</surname><given-names>IP</given-names></name><name><surname>Crane</surname><given-names>CJ</given-names></name><etal>et al.</etal></person-group><article-title>Excisional goniotomy vs trabecular microbypass stent implantation: A prospective randomized clinical trial in eyes with mild to moderate open-angle glaucoma.</article-title><source>J Cataract Refract Surg</source><year>2020</year><volume>46</volume><issue>8</issue><fpage>1165</fpage><lpage>1171</lpage><pub-id pub-id-type="doi">10.1097/j.jcrs.0000000000000229</pub-id><pub-id pub-id-type="pmid">32358417</pub-id></element-citation></ref><ref id="B33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorairaj</surname><given-names>SK</given-names></name><name><surname>Kahook</surname><given-names>MY</given-names></name><name><surname>Williamson</surname><given-names>BK</given-names></name><etal>et al.</etal></person-group><article-title>A multicenter retrospective comparison of goniotomy versus trabecular bypass device implantation in glaucoma patients undergoing cataract extraction.</article-title><source>Clin Ophthalmol</source><year>2018</year><volume>12</volume><fpage>791</fpage><lpage>797</lpage><pub-id pub-id-type="doi">10.2147/OPTH.S158403</pub-id><pub-id pub-id-type="pmid">29750011</pub-id></element-citation></ref><ref id="B34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>ElMallah</surname><given-names>MK</given-names></name><name><surname>Seibold</surname><given-names>LK</given-names></name><name><surname>Kahook</surname><given-names>MY</given-names></name><etal>et al.</etal></person-group><article-title>12-month retrospective comparison of Kahook Dual Blade excisional goniotomy with istent trabecular bypass device implantation in glaucomatous eyes at the time of cataract surgery.</article-title><source>Adv Ther</source><year>2019</year><volume>36</volume><issue>9</issue><fpage>2515</fpage><lpage>2527</lpage><pub-id pub-id-type="doi">10.1007/s12325-019-01025-1</pub-id><pub-id pub-id-type="pmid">31317390</pub-id></element-citation></ref><ref id="B35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le</surname><given-names>C</given-names></name><name><surname>Kazaryan</surname><given-names>S</given-names></name><name><surname>Hubbell</surname><given-names>M</given-names></name><etal>et al.</etal></person-group><article-title>Surgical outcomes of phacoemulsification followed by iStent implantation versus goniotomy with the Kahook Dual Blade in patients with mild primary open-angle glaucoma with a minimum of 12-month follow-up.</article-title><source>J Glaucoma</source><year>2019</year><volume>28</volume><issue>5</issue><fpage>411</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1097/IJG.0000000000001143</pub-id><pub-id pub-id-type="pmid">31048639</pub-id></element-citation></ref><ref id="B36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>D</given-names></name><name><surname>King</surname><given-names>J</given-names></name><name><surname>Thomsen</surname><given-names>S</given-names></name><etal>et al.</etal></person-group><article-title>Comparison of surgical outcomes between excisional goniotomy using the Kahook Dual Blade and iStent trabecular micro-bypass stent in combination with phacoemulsification.</article-title><source>Clin Ophthalmol</source><year>2019</year><volume>13</volume><fpage>2097</fpage><lpage>2102</lpage><pub-id pub-id-type="doi">10.2147/OPTH.S224109</pub-id><pub-id pub-id-type="pmid">31749607</pub-id></element-citation></ref><ref id="B37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwasaki</surname><given-names>K</given-names></name><name><surname>Takamura</surname><given-names>Y</given-names></name><name><surname>Orii</surname><given-names>Y</given-names></name><etal>et al.</etal></person-group><article-title>Performances of glaucoma operations with Kahook Dual Blade or iStent combined with phacoemulsification in Japanese open angle glaucoma patients.</article-title><source>Int J Ophthalmol</source><year>2020</year><volume>13</volume><issue>6</issue><fpage>941</fpage><lpage>945</lpage><pub-id pub-id-type="doi">10.18240/ijo.2020.06.13</pub-id><pub-id pub-id-type="pmid">32566506</pub-id></element-citation></ref><ref id="B38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirabayashi</surname><given-names>MT</given-names></name><name><surname>Lee</surname><given-names>D</given-names></name><name><surname>King</surname><given-names>JT</given-names></name><etal>et al.</etal></person-group><article-title>Comparison of surgical outcomes of 360 degrees circumferential trabeculotomy versus sectoral excisional goniotomy with the Kahook Dual Blade at 6 months.</article-title><source>Clin Ophthalmol</source><year>2019</year><volume>13</volume><fpage>2017</fpage><lpage>2024</lpage><pub-id pub-id-type="doi">10.2147/OPTH.S208468</pub-id><pub-id pub-id-type="pmid">31686776</pub-id></element-citation></ref><ref id="B39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omoto</surname><given-names>T</given-names></name><name><surname>Fujishiro</surname><given-names>T</given-names></name><name><surname>Asano-Shimizu</surname><given-names>K</given-names></name><etal>et al.</etal></person-group><article-title>Comparison of the short-term effectiveness and safety profile of ab interno combined trabeculotomy using 2 types of trabecular hooks.</article-title><source>Jpn J Ophthalmol</source><year>2020</year><volume>64</volume><issue>4</issue><fpage>407</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1007/s10384-020-00750-3</pub-id><pub-id pub-id-type="pmid">32533393</pub-id></element-citation></ref><ref id="B40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorairaj</surname><given-names>SK</given-names></name><name><surname>Seibold</surname><given-names>LK</given-names></name><name><surname>Radcliffe</surname><given-names>NM</given-names></name><etal>et al.</etal></person-group><article-title>12-month outcomes of goniotomy performed using the Kahook Dual Blade combined with cataract surgery in eyes with medically treated glaucoma.</article-title><source>Adv Ther</source><year>2018</year><volume>35</volume><issue>9</issue><fpage>1460</fpage><lpage>1469</lpage><pub-id pub-id-type="doi">10.1007/s12325-018-0755-4</pub-id><pub-id pub-id-type="pmid">30078175</pub-id></element-citation></ref><ref id="B41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kornmann</surname><given-names>HL</given-names></name><name><surname>Fellman</surname><given-names>RL</given-names></name><name><surname>Feuer</surname><given-names>WJ</given-names></name><etal>et al.</etal></person-group><article-title>Early results of goniotomy with the Kahook Dual Blade, a novel device for the treatment of glaucoma.</article-title><source>Clin Ophthalmol</source><year>2019</year><volume>13</volume><fpage>2369</fpage><lpage>2376</lpage><pub-id pub-id-type="doi">10.2147/OPTH.S224643</pub-id><pub-id pub-id-type="pmid">31819362</pub-id></element-citation></ref><ref id="B42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirabayashi</surname><given-names>MT</given-names></name><name><surname>King</surname><given-names>JT</given-names></name><name><surname>Lee</surname><given-names>D</given-names></name><etal>et al.</etal></person-group><article-title>Outcome of phacoemulsification combined with excisional goniotomy using the Kahook Dual Blade in severe glaucoma patients at 6 months.</article-title><source>Clin Ophthalmol</source><year>2019</year><volume>13</volume><fpage>715</fpage><lpage>721</lpage><pub-id pub-id-type="doi">10.2147/OPTH.S196105</pub-id><pub-id pub-id-type="pmid">31114149</pub-id></element-citation></ref><ref id="B43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sieck</surname><given-names>EG</given-names></name><name><surname>Capitena Young</surname><given-names>CE</given-names></name><name><surname>Epstein</surname><given-names>RS</given-names></name><etal>et al.</etal></person-group><article-title>Refractive outcomes among glaucoma patients undergoing phacoemulsification cataract extraction with and without Kahook Dual Blade goniotomy.</article-title><source>Eye Vis (Lond)</source><year>2019</year><volume>6</volume><fpage>28</fpage><pub-id pub-id-type="doi">10.1186/s40662-019-0153-2</pub-id><pub-id pub-id-type="pmid">31548974</pub-id></element-citation></ref><ref id="B44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capitena Young</surname><given-names>CE</given-names></name><name><surname>Ammar</surname><given-names>DA</given-names></name><name><surname>Seibold</surname><given-names>LK</given-names></name><etal>et al.</etal></person-group><article-title>Histopathologic examination of trabecular meshwork changes after trabecular bypass stent implantation.</article-title><source>J Glaucoma</source><year>2018</year><volume>27</volume><issue>7</issue><fpage>606</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1097/IJG.0000000000000968</pub-id><pub-id pub-id-type="pmid">29965891</pub-id></element-citation></ref><ref id="B45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorairaj</surname><given-names>S</given-names></name><name><surname>Tam</surname><given-names>MD</given-names></name></person-group><article-title>Kahook Dual Blade excisional goniotomy and goniosynechialysis combined with phacoemulsification for angle-closure glaucoma: 6-month results.</article-title><source>J Glaucoma</source><year>2019</year><volume>28</volume><issue>7</issue><fpage>643</fpage><lpage>646</lpage><pub-id pub-id-type="doi">10.1097/IJG.0000000000001256</pub-id><pub-id pub-id-type="pmid">30950968</pub-id></element-citation></ref><ref id="B46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorairaj</surname><given-names>S</given-names></name><name><surname>Tam</surname><given-names>MD</given-names></name><name><surname>Balasubramani</surname><given-names>GK</given-names></name></person-group><article-title>Twelve-month outcomes of excisional goniotomy using the Kahook Dual Blade&#x000ae; in eyes with angle-closure glaucoma.</article-title><source>Clin Ophthalmol</source><year>2019</year><volume>13</volume><fpage>1779</fpage><lpage>1785</lpage><pub-id pub-id-type="doi">10.2147/OPTH.S221299</pub-id><pub-id pub-id-type="pmid">31571816</pub-id></element-citation></ref><ref id="B47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorairaj</surname><given-names>S</given-names></name><name><surname>Tam</surname><given-names>MD</given-names></name><name><surname>Balasubramani</surname><given-names>G</given-names></name></person-group><article-title>Two-year clinical outcomes of combined phacoemulsification, goniosynechialysis, and excisional goniotomy for angle-closure glaucoma.</article-title><source>Asia Pac J Ophthalmol (Phila)</source><year>2020</year><volume>10</volume><issue>2</issue><fpage>183</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1097/APO.0000000000000321</pub-id><pub-id pub-id-type="pmid">33031110</pub-id></element-citation></ref><ref id="B48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>VJ</given-names></name><name><surname>Young</surname><given-names>CEC</given-names></name><name><surname>SooHoo</surname><given-names>JR</given-names></name><etal>et al.</etal></person-group><article-title>Efficacy of goniotomy with Kahook Dual Blade in patients with uveitis-associated ocular hypertension.</article-title><source>J Glaucoma</source><year>2019</year><volume>28</volume><issue>8</issue><fpage>744</fpage><lpage>748</lpage><pub-id pub-id-type="doi">10.1097/IJG.0000000000001298</pub-id><pub-id pub-id-type="pmid">31188228</pub-id></element-citation></ref><ref id="B49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khouri</surname><given-names>AS</given-names></name><name><surname>Wong</surname><given-names>SH</given-names></name></person-group><article-title>Ab interno trabeculectomy with a dual blade: surgical technique for childhood glaucoma.</article-title><source>J Glaucoma</source><year>2017</year><volume>26</volume><issue>8</issue><fpage>749</fpage><lpage>751</lpage><pub-id pub-id-type="doi">10.1097/IJG.0000000000000701</pub-id><pub-id pub-id-type="pmid">28598962</pub-id></element-citation></ref><ref id="B50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harvey</surname><given-names>MM</given-names></name><name><surname>Schmitz</surname><given-names>JW</given-names></name></person-group><article-title>Use of ab interno Kahook Dual Blade trabeculectomy for treatment of primary congenital glaucoma.</article-title><source>Eur J Ophthalmol</source><year>2018</year><volume>30</volume><issue>1</issue><fpage>NP16</fpage><lpage>NP20</lpage><pub-id pub-id-type="doi">10.1177/1120672118805873</pub-id><pub-id pub-id-type="pmid">30318913</pub-id></element-citation></ref><ref id="B51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khouri</surname><given-names>AS</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Sadek</surname><given-names>H</given-names></name></person-group><article-title>Ab interno trabeculectomy with the dual blade in juvenile open-angle glaucoma.</article-title><source>Eur J Ophthalmol</source><year>2021</year><volume>31</volume><issue>2</issue><fpage>NP43</fpage><lpage>NP45</lpage><pub-id pub-id-type="doi">10.1177/1120672119892440</pub-id><pub-id pub-id-type="pmid">31801364</pub-id></element-citation></ref><ref id="B52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epstein</surname><given-names>R</given-names></name><name><surname>Taravella</surname><given-names>M</given-names></name><name><surname>Pantcheva</surname><given-names>MB</given-names></name></person-group><article-title>Kahook Dual Blade goniotomy in post penetrating keratoplasty steroid-induced ocular hypertension.</article-title><source>Am J Ophthalmol Case Rep</source><year>2020</year><volume>19</volume><fpage>100826</fpage><pub-id pub-id-type="doi">10.1016/j.ajoc.2020.100826</pub-id><pub-id pub-id-type="pmid">32685769</pub-id></element-citation></ref><ref id="B53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbosa</surname><given-names>NB</given-names></name><name><surname>Grippo</surname><given-names>TM</given-names></name></person-group><article-title>Excisional goniotomy with Kahook Dual Blade in a patient with glaucoma secondary to Transthyretin Amyloidosis.</article-title><source>Am J Ophthalmol Case Rep</source><year>2020</year><volume>19</volume><fpage>100750</fpage><pub-id pub-id-type="doi">10.1016/j.ajoc.2020.100750</pub-id><pub-id pub-id-type="pmid">32514488</pub-id></element-citation></ref><ref id="B54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lichter</surname><given-names>PR</given-names></name><name><surname>Musch</surname><given-names>DC</given-names></name><name><surname>Gillespie</surname><given-names>BW</given-names></name><etal>et al.</etal></person-group><article-title>Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery.</article-title><source>Ophthalmology</source><year>2001</year><volume>108</volume><issue>11</issue><fpage>1943</fpage><lpage>1953</lpage><pub-id pub-id-type="doi">10.1016/s0161-6420(01)00873-9</pub-id><pub-id pub-id-type="pmid">11713061</pub-id></element-citation></ref></ref-list></back></article>
